Altre lingue Cannara Biotech Inc.

Azioni

LOVE

CA13765U2002

Tempo differito Toronto S.E. Altri mercati azionari 15:30:00 03/06/2024			Variaz. 5gg	Var. 1 gen.
0,79 ^CAD	+9,72%		+5,33%	-4,82%

29/04	Cannara Biotech diventa negativa e riporta una perdita netta più ampia nel secondo trimestre rispetto all'anno precedente, nonostante un aumento delle entrate del 51%.	MT
29/04	Cannara Biotech Inc. riporta i risultati degli utili per il secondo trimestre e i sei mesi conclusi il 29 febbraio 2024	CI

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Registrazione 100% gratuita

Cannara Biotech Turns Negative As Reports Wider Q2 Net Loss Vs a Year Ago, Despite Revenue up 51%	29/04
Cannara Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	29/04
Cannara Biotech Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023	29/01
Cannara Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	07/12
Cannara Biotech's Fiscal Q4 Profit, Revenue Grows; Up 9.4%	07/12
Cannara Biotech Inc. Reports Earnings Results for the Fourth Quarter Ended August 31, 2023	07/12
Cannara Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023	27/07/23
Cannara Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023	24/04/23
Cannara Biotech Down Near 8% As Enters into an Automatic Share Purchase Plan	28/02/23
Cannara Biotech Inc. Reports Earnings Results for the First Quarter Ended November 30, 2022	23/01/23
Cannara Biotech Inc. announces an Equity Buyback for 15,000,000 shares, representing 1.71% of its issued share capital.	30/11/22
Cannara Biotech Gains 5% as Q4 EPS Unchanged at $0.01 Vs Year Ago; Revenue $11.9 Million Vs $6.5 Million	25/11/22
Cannara Biotech Q4 EPS Unchanged at $0.01 Vs Year Ago; Revenue $11.9 Million Vs $6.5 Million	25/11/22
Cannara Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2022	25/11/22
Cannara Biotech Inc. authorizes a Buyback Plan.	11/11/22
Cannara Biotech Inc. Announces Entry into the British Columbia Market and the Launch of Its First Vape Cartridge and Vape Accessory, Tribal G Mint and Uni Pro Ark	20/09/22
Cannara Signs an Exclusive Brand Partnership with Exotic Genetix in Canada	03/08/22
Cannara Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2022	27/07/22
Cannara Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2022	27/04/22
Cannara Biotech Inc. Reports Earnings Results for the First Quarter Ended November 30, 2021	20/01/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Cannara Biotech Inc.

Azioni

LOVE

CA13765U2002

Altre lingue

Filtri